Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently... see more

OTCPK:ARLZQ - Post Discussion

View:
Post by kuatolives on Oct 14, 2016 3:47pm

Forgettable week.

Wonder how yosprala scripts are doing in the first 2 weeks....
Will be nice to get a big fat press release with some guidance for Q4. Wouldn't expect that for another month though, assuming revenues are in the ballpark of expectations.  Concordia looks to be in its death throes.
Comment by ConfidentDD on Oct 14, 2016 8:21pm
Helo sir. t takes much longer than 2 weeks or even a month, to see take up of a new drug. Patients are on old scripts, and docs wont just call them and hey say "hey I am changing your script" Its not like a 'McDonalds All Day Breakfast' thing. The next PR will be that things are unfolding. The next Q report will be careful. Sell, hold or buy, we similar care. McDonalsquote ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

Dealroom for high-potential pre-IPO opportunities